ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,721 | -22.1% | 5,907 | +3.5% | 0.01% | -20.0% |
| Q2 2023 | $203,619 | +40.4% | 5,710 | 0.0% | 0.01% | +42.9% |
| Q1 2023 | $145,034 | -43.8% | 5,710 | -10.2% | 0.01% | -41.7% |
| Q4 2022 | $257,840 | +22.7% | 6,357 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $210,099 | -6.1% | 6,357 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $223,830 | -23.4% | 6,357 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $292,358 | -89.6% | 6,357 | -85.0% | 0.01% | -73.7% |
| Q4 2021 | $2,811,584 | +3.5% | 42,407 | -2.5% | 0.04% | -2.6% |
| Q3 2021 | $2,715,705 | -27.1% | 43,500 | -3.3% | 0.04% | -25.0% |
| Q2 2021 | $3,723,836 | +26.9% | 44,963 | +1.6% | 0.05% | +18.2% |
| Q1 2021 | $2,935,411 | -13.3% | 44,268 | +0.4% | 0.04% | -13.7% |
| Q4 2020 | $3,383,946 | +72.8% | 44,102 | -3.0% | 0.05% | +50.0% |
| Q3 2020 | $1,958,670 | -4.9% | 45,487 | -4.6% | 0.03% | -8.1% |
| Q2 2020 | $2,059,817 | +31.9% | 47,692 | -12.1% | 0.04% | +12.1% |
| Q1 2020 | $1,561,175 | -54.6% | 54,264 | +0.2% | 0.03% | -42.1% |
| Q4 2019 | $3,436,511 | +301.6% | 54,178 | +78.4% | 0.06% | +280.0% |
| Q3 2019 | $855,798 | +10.5% | 30,369 | +4.0% | 0.02% | +15.4% |
| Q2 2019 | $774,197 | +45.9% | 29,215 | +1.0% | 0.01% | +30.0% |
| Q1 2019 | $530,810 | +47.7% | 28,927 | 0.0% | 0.01% | +42.9% |
| Q4 2018 | $359,273 | -35.2% | 28,927 | 0.0% | 0.01% | -30.0% |
| Q3 2018 | $554,531 | -99.9% | 28,927 | 0.0% | 0.01% | +66.7% |
| Q2 2018 | $393,407,000 | +145606.3% | 28,927 | -21.2% | 0.01% | +200.0% |
| Q3 2016 | $270,000 | +26.2% | 36,692 | -9.0% | 0.00% | 0.0% |
| Q2 2016 | $214,000 | – | 40,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |